Vergoeding 2018-2022 voor ATC-subgroep J05AB : Nucleosiden en nucleotiden (excl. reverse-transcr-remmers)
- Raming voor de totale Zvw-populatie
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| J05AB01 Aciclovir (Zovirax ®) | 321.080 | 264.590 | 435.010 | 325.390 | 287.300 |
| J05AB06 Ganciclovir (Cymevene ®) | . | 165 | 165 | 30 | 678 |
| J05AB09 Famciclovir | 1.321.500 | 1.264.800 | 1.630.700 | 955.150 | 925.410 |
| J05AB11 Valaciclovir (Zelitrex ®) | 1.640.600 | 1.974.400 | 3.100.600 | 2.727.300 | 2.698.000 |
| J05AB14 Valganciclovir (Valcyte ®) | 1.107.300 | 1.068.700 | 746.300 | 675.600 | 768.090 |
| Totaal | 4.390.480 | 4.572.655 | 5.912.775 | 4.683.470 | 4.679.478 |